Bristol Myers, Moderna und Roche ziehen Anti Virus-Index auf Jahreshoch
Der Global Anti Virus Health Net Return Index hat in den zurückliegenden Tagen von der Mehrheit der Indexmitglieder Rückenwind erhalten.…
47,473$
-2,50%
Echtzeit-Aktienkurs Bristol-Myers Squibb Co.
Bid:
Ask:
Nachrichten zur Bristol-Myers Squibb Co. Aktie
Societe Generale cuts Bristol-Myers Squibb to Hold By Investing.com
Societe Generale cuts Bristol-Myers Squibb to Hold…
Bristol-Myers Squibb: Finally Trending Up
…
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024, Featuring Sanofi, Bristol Myers Squibb, Abbott Laboratories, Takeda Pharmaceutical and Amgen
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024" has…
Bristol-Myers Squibb: Turnaround Expected
…
Bristol-Myers Squibb: Compelling Value From The New Products Portfolio And 4.5% Yield
…
Bristol-Myers Squibb Company (BMY) 44th Annual TD Cowen Healthcare Conference (Transcript)
…
Follicular Lymphoma Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies - AbbVie, Genmab, Novartis, Allogene Therapeutics, Pfizer, Genentech, Incyte Corporation, Bristol-Myers Squibb
The dynamics of the follicular lymphoma market are anticipated to change in the coming years owing to the improvement in…
Bristol Myers Squibb completes RayzeBio acquisition By Investing.com
Bristol Myers Squibb completes RayzeBio acquisition…
Milliardendeal: Bristol-Myers will Biopharmaunternehmen Karuna kaufen
NEW YORK (dpa-AFX) - Der US-Pharmakonzern Bristol-Myers Squibb will seinen Konkurrenten Karuna Therapeutics übernehmen. Die…
Zunehmende Konkurrenz für Krebsmedikament macht Pharmakonzern BMS zu schaffen
NEW YORK (dpa-AFX) - Der US-Pharmakonzern Bristol Myers Squibb (BMS) kämpft weiter mit zunehmender Konkurrenz…